Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 07-2009 | 06-2009 | 04-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -452,900 | -446,500 | -467,200 | -452,100 | -482,400 |
| Depreciation Amortization | 476,700 | 424,300 | 53,900 | 407,600 | 38,100 |
| Income taxes - deferred | -5,800 | -4,700 | -4,400 | -4,400 | -4,300 |
| Accounts receivable | 41,700 | 45,800 | 29,500 | 39,000 | 39,200 |
| Accounts payable and accrued liabilities | -17,800 | -22,400 | -6,300 | -27,200 | -7,500 |
| Other Working Capital | -3,100 | -18,000 | -20,900 | -29,100 | -31,300 |
| Other Operating Activity | 41,100 | 74,200 | 484,300 | 71,400 | 473,200 |
| Operating Cash Flow | $79,900 | $52,700 | $68,900 | $5,200 | $25,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,700 | -20,900 | -23,400 | -13,900 | -13,200 |
| Net Acquisitions | -200 | -200 | -2,700 | -2,700 | -2,700 |
| Purchase Of Investment | -52,700 | -52,600 | -53,200 | -51,400 | -52,000 |
| Sale Of Investment | 200 | N/A | 11,900 | N/A | 11,900 |
| Other Investing Activity | -10,800 | -7,800 | -6,900 | -11,300 | -13,900 |
| Investing Cash Flow | $-90,200 | $-81,500 | $-74,300 | $-79,300 | $-69,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -2,600 | N/A | -1,900 | N/A |
| Debt Repayment | -2,700 | N/A | -2,000 | N/A | -1,900 |
| Common Stock Repurchased | -94,100 | -94,100 | -101,200 | -94,100 | -101,200 |
| Financing Cash Flow | $-96,800 | $-96,700 | $-103,200 | $-96,000 | $-103,100 |
| Exchange Rate Effect | 11,200 | 5,700 | -5,000 | 1,000 | -9,400 |
| Beginning Cash Position | 631,400 | 631,400 | 601,900 | 631,400 | 601,900 |
| End Cash Position | 535,500 | 511,600 | 488,300 | 462,300 | 444,500 |
| Net Cash Flow | $-95,900 | $-119,800 | $-113,600 | $-169,100 | $-157,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 79,900 | 52,700 | 68,900 | 5,200 | 25,000 |
| Capital Expenditure | -32,000 | -25,600 | -28,000 | -18,400 | -17,700 |
| Free Cash Flow | 47,900 | 27,100 | 40,900 | -13,200 | 7,300 |